NeonMind Files for U.S. Provisional Patent to Use Psychedelic-Assisted Psychotherapy for Weight Loss Post published:June 4, 2020 Post category:Press Release
Revive Therapeutics Announces Filing of a Pre-CTA Meeting Request with Health Canada and Update on U.S. FDA IND Filing and Phase 3 Clinical Trial Design for Bucillamine in the Treatment of COVID-19 Post published:June 3, 2020 Post category:Press Release
Interview with Shlomi Raz, CEO and Chairman of Eleusis Post published:June 3, 2020 Post category:Interview
Dr. Devon Christie, MD CCFP RTC IFMCP, joins Numinus as Medical Director Post published:June 3, 2020 Post category:Press Release
Red Light Holland Appoints Prominent Real Estate Developer, Brad J. Lamb, as Chairman of the Board of Directors and Provides Corporate Update Post published:June 2, 2020 Post category:Press Release
Pharmadrug Appoints Cannabis Icon Terry Booth as Chairman of Advisory Board Post published:June 2, 2020 Post category:Press Release
Ehave, Inc. To Acquire Mdlink The Largest Telemedicine Platform in The CARICOM Countries And To Launch Mdlink Mental Therapy along with Psychedelic Treatments To Address Mental Health Post published:June 2, 2020 Post category:Press Release
MindMed’s Microdosing Division Further Expands Phase 2 Clinical Trial of Microdosing LSD For Adult ADHD Post published:June 2, 2020 Post category:Press Release
Newleaf Brands Announces its Move into State-of-the-art 7,500 sq. ft. Specialty Mycology R&D and Product Development Lab in Denver, Colorado Post published:June 2, 2020 Post category:Press Release
Ehave, Inc. Adds Adviser For Clinical Trials For Its Cognitive And Psychedelic Opportunities To Medical Advisory Board Post published:June 1, 2020 Post category:Press Release